ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Snr. Principal Operations Engineer – IGA Tech lead at Eli Lilly and Company - ApplyBlast

Snr. Principal Operations Engineer – IGA Tech lead

Eli Lilly and Company

4 months ago

4.0 on Glassdoor

Cork, Ireland

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

A Senior Principal Operations Engineer at Eli Lilly leads the IGA Cork team to manage day-to-day identity incidents and ensure secure access to enterprise resources within the Identity and Access Management platform. The role involves providing technical leadership on 24/7 support, incident resolution, change management, and driving operational excellence while mentoring a high-performing team of engineers.

Responsibilities

Lead and direct the IGA Cork team in identity incident resolution
Ensure secure and timely access to enterprise resources 24/7
Drive operational excellence for IAM platforms and service delivery
Manage and develop high-performing identity operations engineers
Perform root cause analysis and implement corrective actions

Skills

Qualifications

Bachelor's degree in Computer ScienceCISSPCISMITIL certification5+ years in IAM services

About Eli Lilly and Company

lilly.com

Headquarters

Indianapolis, Indiana, United States

Company Size

10001+ employees

Founded

1876

View Profile

Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.